Stay updated on Opregen in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added multiple study locations across California, Florida, Maryland, Missouri, Ohio, Pennsylvania, Tennessee, Texas, Virginia, and Washington. Updated eligibility criteria to require BCVA between 29 and 60 ETDRS letters and OpRegen dosing up to approximately 200,000 cells; revision 3.3.3 and a new Last Update Posted timestamp were recorded.
    Difference
    2%
    Check dated 2025-12-23T21:09:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new 'Last Update Posted (Estimated)' field has been added to the Study Record Dates, and the previous 'Last Update Posted' field has been removed.
    Difference
    0.1%
    Check dated 2025-12-02T13:11:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added an auto-fill note for Publications indicating PubMed-derived articles may not be related to the study, and updated last update information and revision to v3.3.2; previous PubMed notes and an estimated update timestamp were removed.
    Difference
    0.4%
    Check dated 2025-11-25T10:34:45.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed the government funding status notice, a non-critical item, while core study details remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:18.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The new screenshot shows updates to the study record metadata (last update date) and minor wording changes in the Study Overview. These changes do not alter core study details or participant eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:50:40.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    New recruitment sites were added: Retina Consultants of Texas (Bellaire, TX) and Retina Vitreous Associates of Florida (St. Petersburg, FL). The total number of locations is updated to 15.
    Difference
    0.7%
    Check dated 2025-10-27T18:01:12.000Z thumbnail image

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.